CLINICAL_TRIALS
trial_result
· 2024-02-08
Clinical Trial Update: Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia [Phase 2]
Summary
A Phase 2 continuation study of Recifercept in achondroplasia has terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Achondroplasia | Phase 2 | Status: TERMINATED | Results posted: 2024-02-08